Quercetin, the primary active component of Uncaria Rhynchophylla, alleviates atopic dermatitis through the PPARD pathway: Integrating network pharmacology prediction and experimental validation
Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100591
DOI: 10.1016/j.lddd.2026.100591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Qing Wu und 6 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Basic Research Program of Shaanxi Province, Natural Science Foundation for Young Scientists of Shanxi Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Natural Science Basic Research Program of Shaanxi Province
- Natural Science Foundation for Young Scientists of Shanxi Province
Zitieren
APA
Wu, Q., Chen, D., Liu, J., Zhao, W., Wen, X., Zhang, K., & Yan, Y. (2026). Quercetin, the primary active component of Uncaria Rhynchophylla, alleviates atopic dermatitis through the PPARD pathway: Integrating network pharmacology prediction and experimental validation. Letters in Drug Design & Discovery, 23(9), 100591. https://doi.org/10.1016/j.lddd.2026.100591
Vancouver
Wu Q, Chen D, Liu J, Zhao W, Wen X, Zhang K, et al. Quercetin, the primary active component of Uncaria Rhynchophylla, alleviates atopic dermatitis through the PPARD pathway: Integrating network pharmacology prediction and experimental validation. Letters in Drug Design & Discovery. 2026;23(9):100591. doi:10.1016/j.lddd.2026.100591
BibTeX
@article{Wu2026,
author = {Wu, Qing and Chen, Dacan and Liu, Junfeng and Zhao, Wei and Wen, Xiaowen and Zhang, Kaibo and Yan, Yongyi},
title = {Quercetin, the primary active component of Uncaria Rhynchophylla, alleviates atopic dermatitis through the PPARD pathway: Integrating network pharmacology prediction and experimental validation},
journal = {Letters in Drug Design & Discovery},
year = {2026},
volume = {23},
number = {9},
pages = {100591},
doi = {10.1016/j.lddd.2026.100591}
}
EUVIMED